{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:57:49Z","timestamp":1790517469008,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,27]]},"DOI":"10.7759\/cureus.117000","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:43Z","timestamp":1790516563000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Recurrent Gastrointestinal Bleeding Leading to the Diagnosis of Hereditary Hemorrhagic Telangiectasia: Clinical Response to Systemic Bevacizumab in a Case Report and Narrative Review"],"prefix":"10.7759","author":[{"given":"Btissam","family":"Ess\u00e2di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoub","family":"Bouziane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouiam","family":"Elmqaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Koulali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghizlane","family":"Kharrasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkrim","family":"Zazour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan ME","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, et al.. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020, 173:989-1001. 10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2025.12.025","article-title":"Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases","volume":"24","author":"Gaetani E","year":"2026","unstructured":"Gaetani E, Giovannetti A, Di Martino L, et al.. Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases. J Thromb Haemost. 2026, 24:3325-32. 10.1016\/j.jtha.2025.12.025","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70011","article-title":"Standardization of terminology, definitions, and outcome criteria for bleeding in hereditary hemorrhagic telangiectasia: international consensus report","volume":"100","author":"Al-Samkari H","year":"2025","unstructured":"Al-Samkari H, Kasthuri RS, Mager HJ, et al.. Standardization of terminology, definitions, and outcome criteria for bleeding in hereditary hemorrhagic telangiectasia: international consensus report. Am J Hematol. 2025, 100:1813-27. 10.1002\/ajh.70011","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari H","year":"2021","unstructured":"Al-Samkari H, Kasthuri RS, Parambil JG, et al.. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2021, 106:2161-9. 10.3324\/haematol.2020.261859","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh RN","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973, 60:646-9. 10.1002\/bjs.1800600817","journal-title":"Br J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath PS","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33:464-70. 10.1053\/jhep.2001.22172","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin CL","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, et al.. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 91:66-7. 10.1002\/(sici)1096-8628(20000306)91:1&lt;66::aid-ajmg12&gt;3.0.co;2-p","journal-title":"Am J Med Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176379","article-title":"Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances","volume":"134","author":"Al Tabosh T","year":"2024","unstructured":"Al Tabosh T, Al Tarrass M, Tourvieilhe L, Guilhem A, Dupuis-Girod S, Bailly S. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances. J Clin Invest. 2024, 134:176379. 10.1172\/JCI176379","journal-title":"J Clin Invest"},{"key":"ref9","article-title":"Hereditary hemorrhagic telangiectasia","author":"McDonald J","year":"2000","unstructured":"McDonald J, Gossage JR, Stevenson DA. Hereditary hemorrhagic telangiectasia. GeneReviews\u00ae. Adam MP, Bick S, Mirzaa GM (ed): University of Washington, Seattle, WA; 2000."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2026033112","article-title":"Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS)","volume":"148","author":"Al-Samkari H","year":"2026","unstructured":"Al-Samkari H, Friday C, Kasthuri RS, et al.. Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS). Blood. 2026, 148:417-32. 10.1182\/blood.2026033112","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2190-9303","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: long-term results of endoscopic treatment","volume":"11","author":"Manfredi G","year":"2023","unstructured":"Manfredi G, Crin\u00f2 SF, Alicante S, et al.. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: long-term results of endoscopic treatment. Endosc Int Open. 2023, 11:E1145-52. 10.1055\/a-2190-9303","journal-title":"Endosc Int Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021765","article-title":"How I treat bleeding in hereditary hemorrhagic telangiectasia","volume":"144","author":"Al-Samkari H","year":"2024","unstructured":"Al-Samkari H. How I treat bleeding in hereditary hemorrhagic telangiectasia. Blood. 2024, 144:940-54. 10.1182\/blood.2023021765","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312749","article-title":"Pomalidomide for epistaxis in hereditary hemorrhagic telangiectasia","volume":"391","author":"Al-Samkari H","year":"2024","unstructured":"Al-Samkari H, Kasthuri RS, Iyer VN, et al.. Pomalidomide for epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med. 2024, 391:1015-27. 10.1056\/NEJMoa2312749","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104575","article-title":"European Reference Network for Rare Vascular Diseases (VASCERN): when and how to use intravenous bevacizumab in hereditary haemorrhagic telangiectasia (HHT)?","volume":"65","author":"Dupuis-Girod S","year":"2022","unstructured":"Dupuis-Girod S, Shovlin CL, Kjeldsen AD, et al.. European Reference Network for Rare Vascular Diseases (VASCERN): when and how to use intravenous bevacizumab in hereditary haemorrhagic telangiectasia (HHT)?. Eur J Med Genet. 2022, 65:104575. 10.1016\/j.ejmg.2022.104575","journal-title":"Eur J Med Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000481289","article-title":"Bevacizumab for refractory gastrointestinal bleeding in Rendu-Osler-Weber disease","volume":"25","author":"Bernardes C","year":"2018","unstructured":"Bernardes C, Santos S, Loureiro R, Borges V, Ramos G. Bevacizumab for refractory gastrointestinal bleeding in Rendu-Osler-Weber disease. GE Port J Gastroenterol. 2018, 25:91-5. 10.1159\/000481289","journal-title":"GE Port J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v8.i12.792","article-title":"Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia","volume":"8","author":"Ou G","year":"2016","unstructured":"Ou G, Galorport C, Enns R. Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. World J Gastrointest Surg. 2016, 8:792-5. 10.4240\/wjgs.v8.i12.792","journal-title":"World J Gastrointest Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2242178","article-title":"Management of refractory gastrointestinal bleeding in hereditary hemorrhagic telangiectasia with bevacizumab","volume":"2021","author":"Masood M","year":"2021","unstructured":"Masood M, Coles M, Sifuentes H. Management of refractory gastrointestinal bleeding in hereditary hemorrhagic telangiectasia with bevacizumab. Case Rep Gastrointest Med. 2021, 2021:2242178. 10.1155\/2021\/2242178","journal-title":"Case Rep Gastrointest Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12890\/2023_004219","article-title":"Treatment of hereditary haemorrhagic telangiectasia with bevacizumab - what more needs to be known?","volume":"11","author":"Morrissey E","year":"2024","unstructured":"Morrissey E, Schmidt-Martin D, Buckley M. Treatment of hereditary haemorrhagic telangiectasia with bevacizumab - what more needs to be known?. Eur J Case Rep Intern Med. 2024, 11:004219. 10.12890\/2023_004219","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000475748","article-title":"Intravenous bevacizumab therapy in a patient with hereditary hemorrhagic telangiectasia, ENG E137K, alcoholic cirrhosis, and portal hypertension","volume":"11","author":"Bertoli LF","year":"2017","unstructured":"Bertoli LF, Lee PL, Lallone L, Barton JC. Intravenous bevacizumab therapy in a patient with hereditary hemorrhagic telangiectasia, ENG E137K, alcoholic cirrhosis, and portal hypertension. Case Rep Gastroenterol. 2017, 11:293-304. 10.1159\/000475748","journal-title":"Case Rep Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i5.675","article-title":"Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia","volume":"15","author":"Ielasi L","year":"2023","unstructured":"Ielasi L, Tonnini M, Piscaglia F, Serio I. Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia. World J Hepatol. 2023, 15:675-87. 10.4254\/wjh.v15.i5.675","journal-title":"World J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/537585-severe-recurrent-gastrointestinal-bleeding-leading-to-the-diagnosis-of-hereditary-hemorrhagic-telangiectasia-clinical-response-to-systemic-bevacizumab-in-a-case-report-and-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:44Z","timestamp":1790516564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/537585-severe-recurrent-gastrointestinal-bleeding-leading-to-the-diagnosis-of-hereditary-hemorrhagic-telangiectasia-clinical-response-to-systemic-bevacizumab-in-a-case-report-and-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.117000","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,27]]}}}